Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CRISPR Therapeutics AG

    NASDAQ: CRSP · Real-Time Price · USD
    59.86
    1.04 (1.77%)
    At close: Aug 15, 2025, 1:20 PM

    CRISPR Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -366.25M -153.61M -650.17M 377.66M
    Depreciation & Amortization
    		 19.26M 19.84M 24.17M 17.95M
    Stock-Based Compensation
    		 86.57M 81.03M 97.95M 102.39M
    Other Working Capital
    		 -18.73M 3.33M 14.38M 27.02M
    Other Non-Cash Items
    		 -38.62M -14.04M 12.47M 14.11M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 156.27M -193.59M 19.84M 26.86M
    Operating Cash Flow
    		 -142.77M -260.38M -495.74M 538.97M
    Capital Expenditures
    		 -1.9M -11.97M -37.19M -81.7M
    Cash Acquisitions
    		 n/a n/a 221.47M 953.73M
    Purchase of Investments
    		 -1.46B -1.07B -1.42B -1.51B
    Sales Maturities Of Investments
    		 1.21B 1.45B 1.2B 555.6M
    Other Investing Acitivies
    		 -23.18M -2.5M -221.47M -953.73M
    Investing Cash Flow
    		 -280.48M 374.65M -258.65M -1.04B
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 29.94M 37.62M 37.68M
    Financial Cash Flow
    		 331.98M 62.66M 38.59M 250.94M
    Net Cash Flow
    		 -91.29M 177.01M -715.88M -245.52M
    Free Cash Flow
    		 -144.68M -272.35M -532.93M 457.27M

    Add to Watchlist